Longevity & BPA transaction support

Robust, up‑to‑date views on longevity trends are critical for pricing, capital and BPA transactions. We analyse experience across your portfolios, benchmark assumptions against the wider market and interpret emerging evidence from medical, demographic and socio‑economic developments.

We then help you translate this insight into practical assumption sets for best estimate and prudential views, including trend, base mortality and key segment assumptions such as age, gender, postcode, deprivation and pension amount. Our focus is on clear rationale, documentation and governance so your assumptions stand up to internal and external challenge.

We also produce industry-standard UK mortality/morbidity tables for the CMI and have experience creating the first mortality/morbidity tables for several developing countries, that have previously relied on tables not based on local insured lives data.

We design, build and refine longevity capital models that are proportionate, transparent and aligned to your risk and capital framework. This includes internal model and standard formula support, calibration and validation, and independent review of existing longevity capital methodologies. 

We help you evidence the link between longevity assumptions, emerging experience, capital requirements and risk appetite, so boards and regulators can see that your capital is robust and well‑targeted. Where needed, we also support stress and scenario design, reverse stress testing and the integration of longevity risk with wider credit, market and underwriting risks.

We help insurers and reinsurers explore and execute capital‑efficient solutions for managing longevity risk, from traditional longevity reinsurance through to capital market structures. This includes assessing the impact of different structures on solvency, earnings and risk appetite, and helping you navigate market capacity and counterparties.

Our support spans feasibility analysis, transaction design and independent review, giving you a clear view of value, risk transfer and potential constraints such as collateral, basis risk and regulatory expectations. We also help you integrate these solutions into your ongoing risk and capital management, including reporting and governance.

We support insurers throughout the BPA lifecycle – from proposition design and pipeline management through to pricing, execution and post‑transaction monitoring. This includes cashflow generation and modelling, ensuring your BPA deals work coherently with asset strategies, matching adjustment and capital requirements.

Our team provides assumption‑setting support tailored to BPA, including longevity, expenses and options, and offers flexible resourcing to bolster pricing and transaction teams at peak times. We also deliver financial strength reviews, data support (including data quality, cleansing and benefit specification) and guidance on GMP equalisation, helping you transact efficiently while protecting value and reputation.